nodes	percent_of_prediction	percent_of_DWPC	metapath
Afatinib—PHKG2—hindbrain—autistic disorder	0.0206	0.0593	CbGeAlD
Afatinib—DYRK1A—hindbrain—autistic disorder	0.0179	0.0514	CbGeAlD
Afatinib—ERBB2—mouth—autistic disorder	0.0163	0.0468	CbGeAlD
Afatinib—PHKG2—brainstem—autistic disorder	0.0118	0.034	CbGeAlD
Afatinib—ERBB4—brainstem—autistic disorder	0.0106	0.0306	CbGeAlD
Afatinib—ERBB4—forebrain—autistic disorder	0.0103	0.0295	CbGeAlD
Afatinib—DYRK1A—brainstem—autistic disorder	0.0102	0.0294	CbGeAlD
Afatinib—DYRK1A—forebrain—autistic disorder	0.00988	0.0284	CbGeAlD
Afatinib—ERBB4—telencephalon—autistic disorder	0.00944	0.0271	CbGeAlD
Afatinib—DYRK1A—telencephalon—autistic disorder	0.00909	0.0261	CbGeAlD
Afatinib—EGFR—telencephalon—autistic disorder	0.00801	0.023	CbGeAlD
Afatinib—ABL1—hindbrain—autistic disorder	0.00778	0.0224	CbGeAlD
Afatinib—ERBB2—digestive system—autistic disorder	0.00721	0.0207	CbGeAlD
Afatinib—IRAK1—telencephalon—autistic disorder	0.00706	0.0203	CbGeAlD
Afatinib—EPHA6—head—autistic disorder	0.00678	0.0195	CbGeAlD
Afatinib—PHKG2—head—autistic disorder	0.00654	0.0188	CbGeAlD
Afatinib—EPHA6—nervous system—autistic disorder	0.00643	0.0185	CbGeAlD
Afatinib—HIPK4—brain—autistic disorder	0.00622	0.0179	CbGeAlD
Afatinib—PHKG2—nervous system—autistic disorder	0.0062	0.0178	CbGeAlD
Afatinib—EPHA6—central nervous system—autistic disorder	0.00619	0.0178	CbGeAlD
Afatinib—PHKG2—central nervous system—autistic disorder	0.00597	0.0172	CbGeAlD
Afatinib—ERBB2—head—autistic disorder	0.00588	0.0169	CbGeAlD
Afatinib—ERBB4—head—autistic disorder	0.00588	0.0169	CbGeAlD
Afatinib—PHKG2—cerebellum—autistic disorder	0.00583	0.0168	CbGeAlD
Afatinib—DYRK1A—head—autistic disorder	0.00566	0.0163	CbGeAlD
Afatinib—ERBB2—nervous system—autistic disorder	0.00557	0.016	CbGeAlD
Afatinib—ERBB4—nervous system—autistic disorder	0.00557	0.016	CbGeAlD
Afatinib—ERBB2—central nervous system—autistic disorder	0.00537	0.0154	CbGeAlD
Afatinib—ERBB4—central nervous system—autistic disorder	0.00537	0.0154	CbGeAlD
Afatinib—DYRK1A—nervous system—autistic disorder	0.00537	0.0154	CbGeAlD
Afatinib—ERBB2—cerebellum—autistic disorder	0.00525	0.0151	CbGeAlD
Afatinib—ERBB4—cerebellum—autistic disorder	0.00525	0.0151	CbGeAlD
Afatinib—DYRK1A—central nervous system—autistic disorder	0.00517	0.0148	CbGeAlD
Afatinib—DYRK1A—cerebellum—autistic disorder	0.00505	0.0145	CbGeAlD
Afatinib—EPHA6—brain—autistic disorder	0.00491	0.0141	CbGeAlD
Afatinib—PHKG2—brain—autistic disorder	0.00474	0.0136	CbGeAlD
Afatinib—ABL1—brainstem—autistic disorder	0.00446	0.0128	CbGeAlD
Afatinib—EGFR—cerebellum—autistic disorder	0.00445	0.0128	CbGeAlD
Afatinib—ABL1—eye—autistic disorder	0.00434	0.0125	CbGeAlD
Afatinib—ERBB4—brain—autistic disorder	0.00426	0.0122	CbGeAlD
Afatinib—ERBB2—brain—autistic disorder	0.00426	0.0122	CbGeAlD
Afatinib—DYRK1A—brain—autistic disorder	0.0041	0.0118	CbGeAlD
Afatinib—ABL1—telencephalon—autistic disorder	0.00396	0.0114	CbGeAlD
Afatinib—IRAK1—cerebellum—autistic disorder	0.00392	0.0113	CbGeAlD
Afatinib—EGFR—brain—autistic disorder	0.00361	0.0104	CbGeAlD
Afatinib—IRAK1—brain—autistic disorder	0.00319	0.00916	CbGeAlD
Afatinib—ABL1—digestive system—autistic disorder	0.00302	0.00868	CbGeAlD
Afatinib—ABCG2—telencephalon—autistic disorder	0.00249	0.00717	CbGeAlD
Afatinib—ABL1—head—autistic disorder	0.00246	0.00708	CbGeAlD
Afatinib—ABL1—nervous system—autistic disorder	0.00234	0.00671	CbGeAlD
Afatinib—ABL1—central nervous system—autistic disorder	0.00225	0.00646	CbGeAlD
Afatinib—ABL1—cerebellum—autistic disorder	0.0022	0.00632	CbGeAlD
Afatinib—ABL1—brain—autistic disorder	0.00179	0.00513	CbGeAlD
Afatinib—ABCG2—cerebellum—autistic disorder	0.00139	0.00398	CbGeAlD
Afatinib—ABCB1—forebrain—autistic disorder	0.00134	0.00384	CbGeAlD
Afatinib—ABCB1—telencephalon—autistic disorder	0.00123	0.00354	CbGeAlD
Afatinib—ABCG2—brain—autistic disorder	0.00113	0.00324	CbGeAlD
Afatinib—ABCB1—digestive system—autistic disorder	0.000939	0.0027	CbGeAlD
Afatinib—ABCB1—head—autistic disorder	0.000766	0.0022	CbGeAlD
Afatinib—ABCB1—nervous system—autistic disorder	0.000726	0.00209	CbGeAlD
Afatinib—ABCB1—central nervous system—autistic disorder	0.000699	0.00201	CbGeAlD
Afatinib—ABCB1—cerebellum—autistic disorder	0.000683	0.00196	CbGeAlD
Afatinib—ABCB1—brain—autistic disorder	0.000555	0.0016	CbGeAlD
Afatinib—EGFR—Signaling Pathways—DRD1—autistic disorder	3.75e-05	5.76e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TSC1—autistic disorder	3.75e-05	5.76e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—POMC—autistic disorder	3.75e-05	5.75e-05	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—HRAS—autistic disorder	3.75e-05	5.75e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—TCN2—autistic disorder	3.74e-05	5.74e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—PTEN—autistic disorder	3.72e-05	5.71e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by NGF—IL6—autistic disorder	3.72e-05	5.71e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—ITGB3—autistic disorder	3.69e-05	5.66e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—MAPK1—autistic disorder	3.66e-05	5.61e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IGF1—autistic disorder	3.66e-05	5.61e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—PRKCB—autistic disorder	3.65e-05	5.6e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—NTRK2—autistic disorder	3.65e-05	5.6e-05	CbGpPWpGaD
Afatinib—LCK—Cytokine Signaling in Immune system—IL6—autistic disorder	3.65e-05	5.59e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—DRD3—autistic disorder	3.64e-05	5.58e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TSC1—autistic disorder	3.62e-05	5.55e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD1—autistic disorder	3.62e-05	5.55e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IGF1—autistic disorder	3.6e-05	5.53e-05	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—MAPK1—autistic disorder	3.59e-05	5.51e-05	CbGpPWpGaD
Afatinib—LCK—Signaling by NGF—IL6—autistic disorder	3.59e-05	5.5e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—BCL2—autistic disorder	3.57e-05	5.48e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—ADA—autistic disorder	3.57e-05	5.47e-05	CbGpPWpGaD
Afatinib—ABCB1—Transmembrane transport of small molecules—AVP—autistic disorder	3.57e-05	5.47e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL5—autistic disorder	3.56e-05	5.46e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-A—autistic disorder	3.55e-05	5.44e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IFNG—autistic disorder	3.54e-05	5.43e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—NTRK2—autistic disorder	3.52e-05	5.4e-05	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—HRAS—autistic disorder	3.52e-05	5.4e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—CALCA—autistic disorder	3.51e-05	5.39e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—DRD3—autistic disorder	3.5e-05	5.37e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—SERPINE1—autistic disorder	3.47e-05	5.33e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—EGF—autistic disorder	3.46e-05	5.3e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HTR2A—autistic disorder	3.44e-05	5.28e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL5—autistic disorder	3.43e-05	5.26e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—SERPINE1—autistic disorder	3.42e-05	5.25e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-A—autistic disorder	3.42e-05	5.24e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—PRKCB—autistic disorder	3.42e-05	5.24e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CYP19A1—autistic disorder	3.42e-05	5.24e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—PTEN—autistic disorder	3.4e-05	5.21e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—CALCA—autistic disorder	3.39e-05	5.19e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—TSC2—autistic disorder	3.38e-05	5.19e-05	CbGpPWpGaD
Afatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—autistic disorder	3.38e-05	5.18e-05	CbGpPWpGaD
Afatinib—EGFR—Axon guidance—IL6—autistic disorder	3.37e-05	5.16e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—MAPK1—autistic disorder	3.33e-05	5.1e-05	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—HRAS—autistic disorder	3.32e-05	5.09e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—MTHFR—autistic disorder	3.28e-05	5.04e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—MAPK1—autistic disorder	3.28e-05	5.03e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—HLA-A—autistic disorder	3.27e-05	5.02e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—PTEN—autistic disorder	3.27e-05	5.02e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—TSC2—autistic disorder	3.27e-05	5.02e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—PIK3CG—autistic disorder	3.27e-05	5.02e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—PTEN—autistic disorder	3.26e-05	5e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—TSC2—autistic disorder	3.26e-05	5e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—RORA—autistic disorder	3.25e-05	4.99e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HLA-DRB1—autistic disorder	3.24e-05	4.97e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—MAPK1—autistic disorder	3.23e-05	4.96e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—LEP—autistic disorder	3.2e-05	4.91e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—APOE—autistic disorder	3.2e-05	4.91e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—COMT—autistic disorder	3.18e-05	4.87e-05	CbGpPWpGaD
Afatinib—IRAK1—Innate Immune System—IL6—autistic disorder	3.17e-05	4.87e-05	CbGpPWpGaD
Afatinib—LCK—Disease—MTHFR—autistic disorder	3.16e-05	4.85e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GSTP1—autistic disorder	3.16e-05	4.85e-05	CbGpPWpGaD
Afatinib—LCK—Disease—HLA-A—autistic disorder	3.16e-05	4.84e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MAOA—autistic disorder	3.15e-05	4.84e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—MAPK1—autistic disorder	3.15e-05	4.84e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL2—autistic disorder	3.14e-05	4.82e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—PTEN—autistic disorder	3.14e-05	4.82e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—MAPK1—autistic disorder	3.13e-05	4.8e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—TSC2—autistic disorder	3.12e-05	4.79e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HLA-DRB1—autistic disorder	3.12e-05	4.79e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—PRKCB—autistic disorder	3.12e-05	4.79e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—POMC—autistic disorder	3.11e-05	4.77e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PRL—autistic disorder	3.1e-05	4.76e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—CAT—autistic disorder	3.08e-05	4.72e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—MAPK1—autistic disorder	3.07e-05	4.71e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—APOE—autistic disorder	3.06e-05	4.69e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MAOB—autistic disorder	3.05e-05	4.68e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—MAPK1—autistic disorder	3.03e-05	4.64e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PRKCB—autistic disorder	3.02e-05	4.63e-05	CbGpPWpGaD
Afatinib—LCK—Disease—TSC2—autistic disorder	3.01e-05	4.62e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—PRKCB—autistic disorder	3.01e-05	4.61e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PRL—autistic disorder	2.99e-05	4.59e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—PTEN—autistic disorder	2.96e-05	4.54e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—MAPK1—autistic disorder	2.96e-05	4.53e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—EGF—autistic disorder	2.95e-05	4.53e-05	CbGpPWpGaD
Afatinib—LCK—Disease—APOE—autistic disorder	2.95e-05	4.52e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ADRB2—autistic disorder	2.95e-05	4.52e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—HRAS—autistic disorder	2.94e-05	4.51e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PLA2G4A—autistic disorder	2.9e-05	4.46e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GSTM1—autistic disorder	2.9e-05	4.46e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PIK3CG—autistic disorder	2.89e-05	4.43e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—APC—autistic disorder	2.89e-05	4.43e-05	CbGpPWpGaD
Afatinib—ABL1—Hemostasis—HRAS—autistic disorder	2.88e-05	4.42e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—EGF—autistic disorder	2.86e-05	4.38e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—NOS2—autistic disorder	2.85e-05	4.37e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—EGF—autistic disorder	2.85e-05	4.37e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ADRB2—autistic disorder	2.84e-05	4.35e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—TPH2—autistic disorder	2.83e-05	4.35e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL2—autistic disorder	2.81e-05	4.31e-05	CbGpPWpGaD
Afatinib—ABL1—Developmental Biology—IL6—autistic disorder	2.81e-05	4.31e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—BCL2—autistic disorder	2.79e-05	4.29e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DPYD—autistic disorder	2.79e-05	4.28e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—GPX1—autistic disorder	2.78e-05	4.27e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL2—autistic disorder	2.77e-05	4.25e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IFNG—autistic disorder	2.77e-05	4.25e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—AVP—autistic disorder	2.77e-05	4.24e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—MAPK1—autistic disorder	2.76e-05	4.24e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—APC—autistic disorder	2.76e-05	4.23e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IGF2—autistic disorder	2.75e-05	4.23e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—POMC—autistic disorder	2.75e-05	4.22e-05	CbGpPWpGaD
Afatinib—LCK—Disease—NOS2—autistic disorder	2.75e-05	4.21e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—EGF—autistic disorder	2.73e-05	4.18e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—HRAS—autistic disorder	2.67e-05	4.1e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—AVP—autistic disorder	2.67e-05	4.09e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—MAPK1—autistic disorder	2.66e-05	4.08e-05	CbGpPWpGaD
Afatinib—LCK—Disease—APC—autistic disorder	2.66e-05	4.08e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IGF2—autistic disorder	2.65e-05	4.07e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—PTEN—autistic disorder	2.65e-05	4.06e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IGF1—autistic disorder	2.65e-05	4.06e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—HRAS—autistic disorder	2.63e-05	4.04e-05	CbGpPWpGaD
Afatinib—LCK—Disease—EGF—autistic disorder	2.63e-05	4.03e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—PTEN—autistic disorder	2.61e-05	4e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PLA2G4A—autistic disorder	2.6e-05	3.99e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—HRAS—autistic disorder	2.59e-05	3.98e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CACNA1C—autistic disorder	2.59e-05	3.98e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—MTHFR—autistic disorder	2.57e-05	3.94e-05	CbGpPWpGaD
Afatinib—ERBB2—Immune System—IL6—autistic disorder	2.56e-05	3.92e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—HRAS—autistic disorder	2.53e-05	3.88e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MEF2C—autistic disorder	2.53e-05	3.88e-05	CbGpPWpGaD
Afatinib—ERBB4—Immune System—IL6—autistic disorder	2.52e-05	3.86e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—SERPINE1—autistic disorder	2.51e-05	3.85e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—HRAS—autistic disorder	2.51e-05	3.85e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PLA2G4A—autistic disorder	2.51e-05	3.85e-05	CbGpPWpGaD
Afatinib—ABL1—Innate Immune System—IL6—autistic disorder	2.48e-05	3.81e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—ITGB3—autistic disorder	2.47e-05	3.78e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—HRAS—autistic disorder	2.47e-05	3.78e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL2—autistic disorder	2.46e-05	3.77e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MEF2C—autistic disorder	2.44e-05	3.74e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—HRAS—autistic disorder	2.43e-05	3.73e-05	CbGpPWpGaD
Afatinib—BLK—Immune System—IL6—autistic disorder	2.42e-05	3.72e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—MAPK1—autistic disorder	2.41e-05	3.69e-05	CbGpPWpGaD
Afatinib—EGFR—Developmental Biology—IL6—autistic disorder	2.4e-05	3.69e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—SERPINE1—autistic disorder	2.4e-05	3.68e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—APOE—autistic disorder	2.39e-05	3.67e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—BCL2—autistic disorder	2.39e-05	3.66e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—ITGB3—autistic disorder	2.38e-05	3.65e-05	CbGpPWpGaD
Afatinib—LCK—Hemostasis—HRAS—autistic disorder	2.37e-05	3.64e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IFNG—autistic disorder	2.37e-05	3.63e-05	CbGpPWpGaD
Afatinib—ERBB2—Disease—IL6—autistic disorder	2.36e-05	3.62e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—DHFR—autistic disorder	2.36e-05	3.62e-05	CbGpPWpGaD
Afatinib—ERBB4—Disease—IL6—autistic disorder	2.33e-05	3.57e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—PTEN—autistic disorder	2.32e-05	3.55e-05	CbGpPWpGaD
Afatinib—LCK—Disease—SERPINE1—autistic disorder	2.31e-05	3.55e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HTR2A—autistic disorder	2.3e-05	3.53e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—BCL2—autistic disorder	2.3e-05	3.53e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL2—autistic disorder	2.3e-05	3.53e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IFNG—autistic disorder	2.28e-05	3.5e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HTR2A—autistic disorder	2.22e-05	3.4e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—HRAS—autistic disorder	2.22e-05	3.4e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—TSC2—autistic disorder	2.19e-05	3.35e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PIK3CG—autistic disorder	2.16e-05	3.31e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—MAPK1—autistic disorder	2.15e-05	3.3e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APOE—autistic disorder	2.14e-05	3.28e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—LEP—autistic disorder	2.14e-05	3.28e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—HRAS—autistic disorder	2.14e-05	3.28e-05	CbGpPWpGaD
Afatinib—EGFR—Adaptive Immune System—HRAS—autistic disorder	2.13e-05	3.27e-05	CbGpPWpGaD
Afatinib—EGFR—Innate Immune System—IL6—autistic disorder	2.12e-05	3.25e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—MAPK1—autistic disorder	2.12e-05	3.25e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—TSC2—autistic disorder	2.11e-05	3.23e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL2—autistic disorder	2.1e-05	3.22e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PTGS2—autistic disorder	2.09e-05	3.21e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APOE—autistic disorder	2.06e-05	3.16e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—LEP—autistic disorder	2.06e-05	3.16e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—POMC—autistic disorder	2.05e-05	3.15e-05	CbGpPWpGaD
Afatinib—LCK—Adaptive Immune System—HRAS—autistic disorder	2.05e-05	3.15e-05	CbGpPWpGaD
Afatinib—LCK—Innate Immune System—IL6—autistic disorder	2.04e-05	3.14e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL2—autistic disorder	2.03e-05	3.12e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL2—autistic disorder	2.03e-05	3.11e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PRKCB—autistic disorder	2.02e-05	3.1e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PTGS2—autistic disorder	2.02e-05	3.1e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—PTEN—autistic disorder	1.98e-05	3.03e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PRKCB—autistic disorder	1.95e-05	2.98e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—APC—autistic disorder	1.93e-05	2.96e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PIK3CG—autistic disorder	1.93e-05	2.96e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—HRAS—autistic disorder	1.93e-05	2.96e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—PTEN—autistic disorder	1.91e-05	2.93e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—EGF—autistic disorder	1.91e-05	2.93e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—PTEN—autistic disorder	1.91e-05	2.92e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—MAPK1—autistic disorder	1.88e-05	2.89e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—APC—autistic disorder	1.86e-05	2.86e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PIK3CG—autistic disorder	1.86e-05	2.86e-05	CbGpPWpGaD
Afatinib—IRAK1—Immune System—IL6—autistic disorder	1.85e-05	2.83e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CYP19A1—autistic disorder	1.85e-05	2.83e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—EGF—autistic disorder	1.84e-05	2.82e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—POMC—autistic disorder	1.84e-05	2.82e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—PTEN—autistic disorder	1.83e-05	2.8e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—POMC—autistic disorder	1.77e-05	2.72e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IGF1—autistic disorder	1.77e-05	2.71e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—MAPK1—autistic disorder	1.76e-05	2.7e-05	CbGpPWpGaD
Afatinib—LCK—Disease—PTEN—autistic disorder	1.76e-05	2.7e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—HRAS—autistic disorder	1.73e-05	2.65e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—COMT—autistic disorder	1.72e-05	2.63e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTP1—autistic disorder	1.71e-05	2.62e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MAOA—autistic disorder	1.7e-05	2.62e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IGF1—autistic disorder	1.7e-05	2.61e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—HRAS—autistic disorder	1.7e-05	2.61e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—SERPINE1—autistic disorder	1.68e-05	2.58e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—CAT—autistic disorder	1.66e-05	2.55e-05	CbGpPWpGaD
Afatinib—ERBB2—Signaling Pathways—IL6—autistic disorder	1.65e-05	2.54e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTGS2—autistic disorder	1.64e-05	2.51e-05	CbGpPWpGaD
Afatinib—ERBB4—Signaling Pathways—IL6—autistic disorder	1.63e-05	2.5e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—SERPINE1—autistic disorder	1.62e-05	2.48e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—MAPK1—autistic disorder	1.61e-05	2.47e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PLA2G4A—autistic disorder	1.57e-05	2.41e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GSTM1—autistic disorder	1.57e-05	2.41e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—MAPK1—autistic disorder	1.56e-05	2.39e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—MAPK1—autistic disorder	1.55e-05	2.38e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—HRAS—autistic disorder	1.51e-05	2.32e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—GPX1—autistic disorder	1.5e-05	2.31e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—MAPK1—autistic disorder	1.49e-05	2.28e-05	CbGpPWpGaD
Afatinib—ABL1—Immune System—IL6—autistic disorder	1.45e-05	2.22e-05	CbGpPWpGaD
Afatinib—LCK—Disease—MAPK1—autistic disorder	1.43e-05	2.19e-05	CbGpPWpGaD
Afatinib—ABCG2—Metabolism—PTEN—autistic disorder	1.43e-05	2.19e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—HRAS—autistic disorder	1.41e-05	2.17e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—MTHFR—autistic disorder	1.39e-05	2.13e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL2—autistic disorder	1.36e-05	2.09e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling by GPCR—IL6—autistic disorder	1.35e-05	2.07e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL2—autistic disorder	1.31e-05	2.01e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—APOE—autistic disorder	1.29e-05	1.98e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—HRAS—autistic disorder	1.29e-05	1.98e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—PTEN—autistic disorder	1.28e-05	1.96e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—HRAS—autistic disorder	1.25e-05	1.91e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—HRAS—autistic disorder	1.24e-05	1.91e-05	CbGpPWpGaD
Afatinib—EGFR—Immune System—IL6—autistic disorder	1.24e-05	1.9e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—PTEN—autistic disorder	1.23e-05	1.89e-05	CbGpPWpGaD
Afatinib—IRAK1—Signaling Pathways—IL6—autistic disorder	1.2e-05	1.83e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—HRAS—autistic disorder	1.19e-05	1.83e-05	CbGpPWpGaD
Afatinib—LCK—Immune System—IL6—autistic disorder	1.19e-05	1.83e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PIK3CG—autistic disorder	1.17e-05	1.79e-05	CbGpPWpGaD
Afatinib—LCK—Disease—HRAS—autistic disorder	1.15e-05	1.76e-05	CbGpPWpGaD
Afatinib—EGFR—Disease—IL6—autistic disorder	1.14e-05	1.75e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—POMC—autistic disorder	1.11e-05	1.7e-05	CbGpPWpGaD
Afatinib—LCK—Disease—IL6—autistic disorder	1.1e-05	1.69e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—MAPK1—autistic disorder	1.04e-05	1.59e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—MAPK1—autistic disorder	1e-05	1.54e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTGS2—autistic disorder	8.85e-06	1.36e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—HRAS—autistic disorder	8.35e-06	1.28e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—HRAS—autistic disorder	8.05e-06	1.23e-05	CbGpPWpGaD
Afatinib—EGFR—Signaling Pathways—IL6—autistic disorder	7.99e-06	1.23e-05	CbGpPWpGaD
Afatinib—ABCB1—Metabolism—PTEN—autistic disorder	7.72e-06	1.18e-05	CbGpPWpGaD
Afatinib—LCK—Signaling Pathways—IL6—autistic disorder	7.7e-06	1.18e-05	CbGpPWpGaD
